Cargando…

Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the leading cause of cancer-related deaths, accounting for over a million deaths worldwide annually. Immunogenic cell death (ICD) elicits an adaptive immune response. However, the role of ICD-related long noncoding RNAs (lncRNAs) in LUAD is unknown. In this study, we in...

Descripción completa

Detalles Bibliográficos
Autores principales:	SUN, DONGJIE, ZHANG, CHI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tech Science Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398397/ https://www.ncbi.nlm.nih.gov/pubmed/37547766 http://dx.doi.org/10.32604/or.2023.029287

Ejemplares similares

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2015)

Long Noncoding RNA Expression Profiles of Lung Adenocarcinoma Ascertained by Microarray Analysis
por: Xu, Gang, et al.
Publicado: (2014)

Long Noncoding RNA-LET Suppresses Tumor Growth and EMT in Lung Adenocarcinoma
por: Liu, Bin, et al.
Publicado: (2016)

Genome-wide analyses of long noncoding RNA expression profiles in lung adenocarcinoma
por: Peng, Zhenzi, et al.
Publicado: (2017)

Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation
por: Liu, Liang, et al.
Publicado: (2018)

A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma
por: Bai, Yuquan, et al.
Publicado: (2020)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Expression profiles of long noncoding RNAs in lung adenocarcinoma
por: Zhao, Bing, et al.
Publicado: (2018)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma
por: Chen, Rui, et al.
Publicado: (2019)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma
por: Zhou, Jianlong, et al.
Publicado: (2018)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Profiling expression of coding genes, long noncoding RNA, and circular RNA in lung adenocarcinoma by ribosomal RNA‐depleted RNA sequencing
por: Ding, Xiangxiang, et al.
Publicado: (2018)

Methylation of N6 adenosine‐related long noncoding RNA: effects on prognosis and treatment in ‘driver‐gene‐negative’ lung adenocarcinoma
por: Yang, Hao‐Shuai, et al.
Publicado: (2022)

The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p
por: Yang, Shengzhuang, et al.
Publicado: (2019)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer
por: Huang, Gaomin, et al.
Publicado: (2022)

Long noncoding RNA: noncoding and not coded
por: Toiber, Debra, et al.
Publicado: (2017)

Long noncoding RNA: noncoding and not coded
por: Toiber, Debra, et al.
Publicado: (2017)

The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma
por: Chen, Xinming, et al.
Publicado: (2021)

Impact of Genetic Variants of Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 on Uterine Cervical Cancer
por: Sun, Yi-Hung, et al.
Publicado: (2022)

Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma
por: Qiu, Yuting, et al.
Publicado: (2022)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
por: Xu, Ran, et al.
Publicado: (2017)

Long Noncoding RNA TALAM1 Is a Transcriptional Target of the RUNX2 Transcription Factor in Lung Adenocarcinoma
por: Bermúdez, Gisella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8iscleip458nq0sgv1d1iq2pge